GAN and metabolic dysfunction-associated steatohepatitis: Similar to GAN DIO-NASH-HCC mouse tumors β-catenin-activated human HCCs do often not display steatosis, perhaps due to fatty acid β-oxidative reprogramming to support tumor growth37.